Securities Registration: Employee Benefit Plan (s-8)
May 25 2017 - 5:27PM
Edgar (US Regulatory)
As filed with the Securities and Exchange
Commission on May 25, 2017
Registration Number 333-
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Medifast,
Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
|
13-3714405
(I.R.S. Employer
Identification Number)
|
Medifast, Inc.
3600 Crondall Lane
Owings Mills, Maryland 21117
(
Address of Principal Executive Offices)
Medifast, Inc. Amended and Restated 2012
Share Incentive Plan
(Full titles of the plans)
Jason L. Groves, Esq.
Executive Vice President, General Counsel & Corporate Secretary
Medifast, Inc.
3600 Crondall Lane
Owings Mills, Maryland
Tel: (410) 581-8042
Copy to:
Bryan Brown, Esq.
Reed Smith LLP
811 Main Street, Suite 1700
Houston, Texas 77002
Tel: (713) 469-3894
Fax: (713) 469-3899
(Name, address and telephone number (including area code) of agent for service)
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated
filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check
one):
Large accelerated filer
¨
|
Accelerated filer
x
|
|
|
Non-accelerated filer
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
¨
|
CALCULATION OF REGISTRATION FEE
Title of Securities
to be registered
|
|
Amount
to be
registered
(1)
|
|
|
Proposed
maximum
offering price
per share
(3)
|
|
|
Proposed
maximum
aggregate
offering price
(3)
|
|
|
Amount of
registration fee
|
|
Common Stock, par value $0.001 per share
|
|
|
600,000
|
(2)
|
|
$
|
42.85
|
|
|
$
|
25,710,000
|
|
|
$
|
2,979.79
|
|
|
(1)
|
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement
also covers such indeterminable number of additional shares of the Registrant’s common stock, par value $0.001 per share
(the “Common Stock”), that become issuable under the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan,
as amended and restated (the “Amended and Restated 2012 Plan”), by reason of any stock splits, stock dividends, recapitalization
or similar transactions.
|
|
(2)
|
Represents 600,000 additional shares of Common Stock that are available for grant under the Amended and Restated 2012 Plan,
as amended and approved by the Registrant’s stockholders at its annual meeting on May 18, 2017.
|
|
(3)
|
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) of the Securities
Act. The offering price per share and aggregate offering price are based upon the average of the high and low prices for the Common
Stock as reported on the New York Stock Exchange on May 19, 2017, which date is within five business days prior to filing this
Registration Statement in accordance with Rule 457(c) of the Securities Act.
|
EXPLANATORY NOTE
This Registration Statement
is filed by the Registrant pursuant to General Instruction E to Form S-8 to register an additional 600,000 shares of the Registrant’s
common stock, par value $0.001 per share (the “Common Stock”), which may be awarded under the Medifast, Inc. Amended
and Restated 2012 Share Incentive Plan (the “Plan”). On May 18, 2017, the Registrant’s stockholders approved
the amendment and restatement of the Plan that increased by 600,000 the number of shares of Common Stock with respect to which
the Registrant may make awards under the Plan. The contents of the Registrant’s Registration Statement on Form S-8 filed
April 18, 2013 registering 1,000,000 shares of Common Stock (Commission File No. 333-187374) is incorporated herein by reference
and made a part hereof except to the extent supplemented, amended or superseded by the information set forth herein.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a)
PROSPECTUS
The information specified
in Part I of Form S-8 is omitted from this registration statement in accordance with the provisions of Rule 428 under the Securities
Act and the introductory note to Part I of Form S-8. The document(s) containing the information specified in Part I of Form S-8
will be sent or given to participants in the Plan, as required by Rule 428 promulgated by the Securities and Exchange Commission
(the “Commission”) under the Securities Act. Such documents are not being filed with the Commission either as part
of this registration statement or as prospectuses or prospectus supplements pursuant to Rule 424. These documents and the documents
incorporated by reference in the registration statement shall constitute a prospectus that meets the requirements of Section 10(a)
of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION
STATEMENT
Item 8. Exhibits.
Exhibit
Number
|
|
Description of Documents
|
|
|
|
4.1
|
|
Medifast, Inc. Amended and Restated 2012 Share Incentive Plan (incorporated by reference from Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 10, 2017)(File No. 001-31573)
|
|
|
|
5.1
|
|
Opinion of Reed Smith LLP
|
|
|
|
23.1
|
|
Consent of RSM US LLP
|
|
|
|
23.2
|
|
Consent of Reed Smith LLP (included in Exhibit 5.1)
|
|
|
|
24.1
|
|
Power of Attorney (included on signature page hereto)
|
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Owings Mills, State of Maryland, on May 25, 2017.
|
Medifast, Inc.
|
|
|
|
|
|
|
|
By:
|
/s/ Daniel R. Chard
|
|
|
Daniel R. Chard
|
|
|
Chief Executive Officer
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY
THESE PRESENTS, that each person whose signature appears below constitutes and appoints, Daniel R. Chard and Timothy G. Robison
and each of them, his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution,
for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-
effective amendments, to this Registration Statement, and any registration statement relating to the offering covered by this Registration
Statement and filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with exhibits thereto
and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of
them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all
intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact
and agents or their substitute may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities
and on the dates indicated:
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Michael C. MacDonald
|
|
Chairman and Director
|
|
May 25, 2017
|
Michael C. MacDonald
|
|
|
|
|
|
|
|
|
|
/s/ Daniel R. Chard
|
|
Chief Executive Officer
(
Principal Executive Officer
) and Director
|
|
May 25, 2017
|
Daniel R. Chard
|
|
|
|
|
|
|
|
|
|
/s/ Timothy G. Robinson
|
|
Chief Financial Officer
(
Principal Financial Officer
)
|
|
May 25, 2017
|
Timothy G. Robinson
|
|
|
|
|
|
|
|
|
|
/s/ Joseph P. Kelleman
|
|
Vice President of Finance
(
Principal Accounting Officer
)
|
|
May 25, 2017
|
Joseph P. Kelleman
|
|
|
|
|
|
|
|
|
|
/s/ Jeffrey J. Brown
|
|
Director
|
|
May 25, 2017
|
Jeffrey J. Brown
|
|
|
|
|
|
|
|
|
|
/s/ Kevin G. Byrnes
|
|
Director
|
|
May 25, 2017
|
Kevin G. Byrnes
|
|
|
|
|
|
|
|
|
|
/s/ Charles P. Connolly
|
|
Director
|
|
May 25, 2017
|
Charles P. Connolly
|
|
|
|
|
|
|
|
|
|
/s/ Constance J. Hallquist
|
|
Director
|
|
May 25, 2017
|
Constance J. Hallquist
|
|
|
|
|
|
|
|
|
|
/s/ Carl E. Sassano
|
|
Director
|
|
May 25, 2017
|
Carl E. Sassano
|
|
|
|
|
|
|
|
|
|
/s/ Scott Schlackman
|
|
Director
|
|
May 25, 2017
|
Scott Schlackman
|
|
|
|
|
|
|
|
|
|
/s/ Glenn W. Welling
|
|
Director
|
|
May 25, 2017
|
Glenn W. Welling
|
|
|
|
|
INDEX TO EXHIBITS
Exhibit
Number
|
|
Description of Document
|
|
|
|
4.1
|
|
Medifast, Inc. Amended and Restated 2012 Share Incentive Plan (incorporated by reference from Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 10, 2017)(File No. 001-31573)
|
|
|
|
5.1
|
|
Opinion of Reed Smith LLP
|
|
|
|
23.1
|
|
Consent of RSM US LLP
|
|
|
|
23.2
|
|
Consent of Reed Smith LLP (included in Exhibit 5.1)
|
|
|
|
24.1
|
|
Power of Attorney (included on signature page hereto)
|
Medifast (NYSE:MED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medifast (NYSE:MED)
Historical Stock Chart
From Apr 2023 to Apr 2024